163 related articles for article (PubMed ID: 37736904)
1. Methadone Treatment Gap in Tennessee and How Medication Units Could Bridge the Gap: A Review.
Risby J; Schlesinger E; Geminn W; Cernasev A
Pharmacy (Basel); 2023 Aug; 11(5):. PubMed ID: 37736904
[TBL] [Abstract][Full Text] [Related]
2. Expanding access to methadone treatment in Ohio through federally qualified health centers and a chain pharmacy: A geospatial modeling analysis.
Iloglu S; Joudrey PJ; Wang EA; Thornhill TA; Gonsalves G
Drug Alcohol Depend; 2021 Mar; 220():108534. PubMed ID: 33497963
[TBL] [Abstract][Full Text] [Related]
3. Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff.
Wu LT; Mannelli P; John WS; Anderson A; Schwartz RP
Subst Abuse Treat Prev Policy; 2023 Sep; 18(1):55. PubMed ID: 37697326
[TBL] [Abstract][Full Text] [Related]
4. Integration of a Community Opioid Treatment Program into a Federally Qualified Health Center.
Neeb C; McQuade BM; Lesondak L; Madrid S; Schlaeger JM; Watson DP; Karnik N; Huerta N; Bhatia S; Fleurimont J; Li N; Hammerdahl E; Pesantez R; Gastala N
J Addict Med; 2024 Jun; ():. PubMed ID: 38884619
[TBL] [Abstract][Full Text] [Related]
5. Changes In County-Level Access To Medications For Opioid Use Disorder After Medicare Coverage Of Methadone Treatment Began.
Harris SJ; Yarbrough CR; Abraham AJ
Health Aff (Millwood); 2023 Jul; 42(7):991-996. PubMed ID: 37406230
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and current clinical practices of opioid treatment programs in the United States.
Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
[TBL] [Abstract][Full Text] [Related]
7. Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability.
Brooner RK; Stoller KB; Patel P; Wu LT; Yan H; Kidorf M
Drug Alcohol Depend Rep; 2022 Jun; 3():. PubMed ID: 35757566
[TBL] [Abstract][Full Text] [Related]
8. Bridge clinic implementation of "72-hour rule" methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care.
Taylor JL; Laks J; Christine PJ; Kehoe J; Evans J; Kim TW; Farrell NM; White CS; Weinstein ZM; Walley AY
Drug Alcohol Depend; 2022 Jul; 236():109497. PubMed ID: 35607834
[TBL] [Abstract][Full Text] [Related]
9. Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule.
Laks J; Kehoe J; Farrell NM; Komaromy M; Kolodziej J; Walley AY; Taylor JL
Addict Sci Clin Pract; 2021 Dec; 16(1):73. PubMed ID: 34961554
[TBL] [Abstract][Full Text] [Related]
10. Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S.
Wu LT; John WS; Mannelli P; Morse ED; Anderson A; Schwartz RP
Addict Sci Clin Pract; 2023 Aug; 18(1):45. PubMed ID: 37533071
[TBL] [Abstract][Full Text] [Related]
11. Introduction of Medicare coverage in opioid treatment programs: Findings from the first three years.
Abraham AJ; Harris SJ; Yarbrough CR
J Subst Use Addict Treat; 2024 Mar; 158():209247. PubMed ID: 38072386
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US.
Kleinman RA
JAMA Psychiatry; 2020 Nov; 77(11):1163-1171. PubMed ID: 32667648
[TBL] [Abstract][Full Text] [Related]
13. Geographic variation in availability of opioid treatment programs across U.S. communities.
Jehan S; Zahnd WE; Wooten NR; Seay KD
J Addict Dis; 2024; 42(2):136-146. PubMed ID: 36645315
[TBL] [Abstract][Full Text] [Related]
14. Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis.
Levander XA; Hoffman KA; McIlveen JW; McCarty D; Terashima JP; Korthuis PT
Addict Sci Clin Pract; 2021 Dec; 16(1):72. PubMed ID: 34895346
[TBL] [Abstract][Full Text] [Related]
15. Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis.
Anwar T; Duever M; Jayawardhana J
Drug Alcohol Depend; 2022 Sep; 238():109565. PubMed ID: 35839618
[TBL] [Abstract][Full Text] [Related]
16. Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study.
Dickerson SS; George SJ; Ventuneac A; Dharia A; Talal AH
J Med Internet Res; 2024 Jun; 26():e53049. PubMed ID: 38865703
[TBL] [Abstract][Full Text] [Related]
17. The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
Gertner AK; Robertson AG; Jones H; Powell BJ; Silberman P; Domino ME
Health Serv Res; 2020 Jun; 55(3):383-392. PubMed ID: 32166761
[TBL] [Abstract][Full Text] [Related]
18. Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study.
Joudrey PJ; Chadi N; Roy P; Morford KL; Bach P; Kimmel S; Wang EA; Calcaterra SL
Drug Alcohol Depend; 2020 Mar; 211():107968. PubMed ID: 32268248
[TBL] [Abstract][Full Text] [Related]
19. Opioid treatment program culture and philosophy: Views of OTP staff and state officials on implementing interim methadone treatment.
Burruss-Cousins K; Mitchell SG; Gryczynski J; Whitter M; Fuller D; Ibrahim A; Schwartz RP
J Subst Use Addict Treat; 2024 Feb; 157():209265. PubMed ID: 38103832
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
